Nephrol Dial Transplant (2017) 32: 254-264 doi: 10.1093/ndt/gfw202 Advance Access publication 26 May 2016 immune system, age-related alterations in target organs including changes in the microvasculature may contribute to the progression of the disease [12] .
Animal models of AAV have provided important insights into the pathogenesis of AAV [13, 14] . One of the most widely used animal models is an acute passive transfer model that relies on systemic injection of anti-MPO antibodies derived from mouse MPO (mMPO)-immunized Mpo-deficient mice into wildtype C57Bl6 mice. Within 7 days, mice develop urinary abnormalities (haematuria, albuminuria and leukocyturia), crescentic glomerulonephritis and vasculitis [15] . Disease severity can be enhanced by simultaneous injection of lipopolysaccharide (LPS) [16] . However, hitherto only young mice have been studied, which does not accurately reflect the human disease, which predominantly develops in elderly individuals. In this study we aimed to determine the contribution of age to the development of experimental AAV. We induced anti-MPO IgG-mediated glomerulonephritis in young and old mice and evaluated the clinical and pathological disease severity in relation to age-associated alterations of the immune system as well as kidney-specific changes.
M A T E R I A L S A N D M E T H O D S

Mice
Mpo
À/À mice (B6.129X1-Mpotm1Lus/J) were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and bred inhouse. Female C57BL/6JRcc wild-type mice were purchased from Harlan (Horst, The Netherlands). All experimental procedures were performed according to Dutch laws and international guidelines on animal experimentation and were approved by the animal ethics committee of the University of Groningen (DEC 5957C).
Generation of polyclonal mouse anti-MPO IgG
Murine MPO was purified from WEHI-3 cells and used for immunization of Mpo À/À mice as described previously [16] . Total IgG was isolated from pooled sera of immunized Mpo À/À mice, and the anti-MPO IgG titre was analysed by ELISA as reported previously [16] .
Induction of anti-MPO IgG-induced glomerulonephritis
Twenty-nine young (3 months) and 29 old (18 months) C57BL/6 mice were randomly divided into eight treatment groups (Table 1) . For induction of anti-MPO IgG-induced NCGN, young and aged mice received 2.8 mg/mouse anti-MPO IgG intravenously, followed by an intraperitoneal injection of 3000 EU/g bodyweight LPS (Escherichia coli, serotype O26:B6; Sigma-Aldrich, St Louis, MO, USA) 1 h later. Mice were sacrificed after 1 or 7 days. As controls, young and aged mice were either left untreated or received an equal dose of LPS intraperitoneally and were sacrificed after 7 days. Upon sacrifice, kidneys were excised, snap-frozen and stored at À80 C for immunohistochemical and gene expression analyses or fixed in formalin for histopathological evaluation. Plasma (EDTA) and urine (18-h) were collected at baseline, Day 1 and Day 7. Three 
mice were excluded from the analyses since two aged mice had to be prematurely sacrificed due to deteriorating condition and one aged mouse died during the study.
Blood analysis
Total leukocyte counts were determined using the pocH100i (Sysmex Corporation, Europe GmbH, Norderstedt, Germany) haematological analyser. Levels of anti-MPO antibody in plasma were determined by ELISA using a serum pool from MPO immunized Mpo À/À mice as a reference. Plasma interleukin (IL)-6 and tumour necrosis factor-a (TNF-a) were determined using the mouse IL-6 ELISA kit (Biolegend, San Diego, CA, USA) and mouse TNF-a ELISA kit (Biolegend). Obtained values that were below the minimum detection limit were set to the detection limit of the assays used, i.e. 78 pg/mL for IL-6 and 15.6 pg/mL for TNF-a.
Peripheral blood neutrophils and monocytes and their activation status were determined by flow cytometry using rat antimouse CD11b-PE, hamster anti-mouse CD80-APC, rat antimouse Ly6G-FITC and rat anti-mouse CD62L-PerCP-Cy5.5 (all from BD BioSciences). Analyses were performed using Kaluza (Beckman Coulter).
Urinalysis
Spot urine samples were tested every day for haematuria (scale: 0 to 4þ) and leukocyturia (0 to 3þ) by Combur-Test strips (Roche Diagnostics BV, Almere, The Netherlands). Cumulative scores were calculated by the sum of the scores over 7 days. Albuminuria was determined by ELISA in 18-h urine samples (Bethyl Laboratories, Montgomery, TX, USA).
Histological evaluation of renal injury
Haematoxylin and eosin staining was performed on paraffin sections, and the number of glomeruli displaying crescent formation and capillary necrosis was quantified in 100 consecutive glomerular cross sections in a blinded manner, as described previously [17] . Immunohistochemical staining for neutrophils was performed using monoclonal rat anti-mouse Ly6B (AbDSecrotec, Oxford, UK) on paraffin sections. Macrophages were detected by monoclonal rat anti-mouse CD68 (AbDSerotec) on cryostat sections. The number of neutrophils was counted in 50 consecutive glomerular cross sections in a blinded manner and expressed as the mean number of neutrophils per glomerulus. To quantify the extent of macrophage infiltration, sections were scanned using a Nanozoomer Digital Pathology Scanner (Hamamatsu Photonics K.K., Hamamatsu, Japan) and analysed using the Aperio positive pixel analysis v9.1 algorithm (Aperio Technologies, Vista, CA, USA).
Analysis of renal IL-1b protein by ELISA IL-1b protein levels in kidney tissue were measured using an IL-1b ELISA MAX kit (Biolegend). IL-1b protein levels were normalized to the total protein concentration in the tissue homogenate (pg IL-1b/g total protein).
Renal gene expression analysis by real-time RT-PCR
Total RNA was extracted using the RNeasy Mini plus kit (Qiagen, Venlo, The Netherlands). RNA was reversetranscribed and quantitative PCR was performed on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Applera Nederland, Nieuwekerk aan den Ijssel, The Netherlands), using Assay-On-Demand primers (Supplementary data, Table S1 ): mouse glyceraldehyde 3-phosphatedehydrogenase (GAPDH); IL-6; CXCL1; IL-1b; TNF-a; intercellular adhesion molecule-1 (ICAM-1); vascular cell adhesion protein-1 (VCAM-1); mouse CD68; CCR2; MPO; kidney injury molecule 1 (KIM-1); neutrophil gelatinase-associated lipocalin (NGAL); p53; p21; klotho; and E-selectin. The level of gene expression was calculated as previously described [18] . Data are presented as fold induction in comparison with median values of untreated young controls.
Statistical analysis
Data are expressed as median and range unless stated otherwise and were analysed using the Mann-Whitney U-test. All statistical analyses were performed using GraphPad Prism 5.00 for Windows (Graphpad Software, San Diego, CA, USA). P < 0.05 was considered statistically significant.
R E S U L T S
General characteristics of the different experimental groups are shown in Table 1 . As expected, aged mice were heavier than young mice, but body weight was comparable between the different treated groups of the same age. There were no age differences in kidney weight relative to bodyweight. Thymus weight relative to bodyweight appeared to be lower in untreated aged mice compared with young mice (P ¼ 0.061). Interestingly, 7 days after anti-MPO IgG/LPS or LPS-only injection in aged mice, thymus weight relative to bodyweight was lower compared with untreated aged mice. Spleen weight relative to bodyweight was higher in aged than in young mice 7 days after anti-MPO IgG/LPS injection. Since aged mice received the same amount of anti-MPO IgG as young mice but were heavier, lower 
Aged mice develop more severe anti-MPO IgG/LPS-induced glomerulonephritis
After disease induction by anti-MPO IgG/LPS, all mice developed marked haematuria and mild leukocyturia (Figure 2A and B). Comparison of cumulative scores of haematuria and leukocyturia over 7 days revealed that leukocyturia was higher in aged than in young mice ( Figure 2B ). After disease induction by anti-MPO IgG/LPS, both young and old mice developed albuminuria at Day 7 but the extent of albuminuria was significantly higher in aged than in young mice ( Figure 2C ).
Aged mice display more glomerular capillary necrosis upon induction of anti-MPO IgG/LPS
No overt histological differences were found between kidneys of untreated young and aged mice. Additionally, LPS-only treated mice showed normal renal morphology. All mice that received anti-MPO IgG/LPS developed focal and segmental glomerulonephritis with glomerular crescent formation on Day 7 ( Figure 3A and B). Glomerular crescent formation was mild in both young and aged mice and was not statistically different between the two groups ( Figure 3E ). However, in aged mice the amount of glomeruli with capillary necrosis ( Figure 3C and D) was significantly higher than in young mice ( Figure 3E ).
Aged mice display increased glomerular neutrophil accumulation after induction of anti-MPO IgG/LPS
Neutrophils were hardly detected in glomeruli of untreated or LPS-treated young and aged mice. One day after disease induction by anti-MPO IgG/LPS, a focal and segmental glomerular neutrophil influx was observed ( Figure 4A and B). When quantified, we found that glomerular neutrophil influx was higher in aged than in young mice ( Figure 4C ). Aged mice develop more leukocyturia and albuminuria after induction of anti-MPO IgG/LPS-mediated glomerulonephritis than young mice. Urine samples were tested for haematuria (0 to 4þ score) and leukocyturia (0 to 3þ score) for 7 days after induction of anti-MPO IgG/LPS-mediated glomerulonephritis or LPS-only injection and displayed as cumulative score for each mouse. (A) Both young and old mice developed overt haematuria after induction of anti-MPO IgG/LPS-mediated glomerulonephritis. After LPS-only injection modest haematuria was found, which was higher in old than young mice. (B) After induction of anti-MPO IgG/LPS-mediated glomerulonephritis only modest leukocyturia was found, which was higher in old than young mice. (C) After induction of anti-MPO IgG/LPS-mediated glomerulonephritis young and old mice showed increased urinary albumin excretion at Day 7 compared with baseline. At Day 7, albuminuria was higher in old than young mice. After LPS-only injection urinary albumin excretion in young and old mice was comparable to baseline levels. In (A) and (B) horizontal lines indicate median values. In (C) data are expressed as the mean 6 SEM. Comparisons between the two groups were performed by the Mann-Whitney U-test. *P < 0.05; ***P < 0.001
Few macrophages were present in untreated or LPS-treated young and aged mice. Yet, 7 days after disease induction by anti-MPO IgG/LPS, interstitial and periglomerular macrophages were observed ( Figure 4D and E). Quantification revealed that macrophage infiltration was comparable between young and aged mice ( Figure 4F ). Finally, we measured IL-1b levels in kidney homogenates. IL-1b protein levels appeared to be higher in old mice compared with young mice 1 day after disease induction (Supplementary data, Figure S1 ).
Aged mice display increased levels of circulating proinflammatory cytokines after induction of anti-MPO IgG/LPS
White blood cell (WBC) counts and plasma proinflammatory cytokine levels are shown in Figure 5 . WBC counts were lower in untreated aged mice than in young mice. After disease induction with anti-MPO IgG/LPS and LPS-only injection, a decrease in WBC was observed in young mice, whereas in aged mice WBC counts remained unchanged ( Figure 5A ). Plasma levels of the pro-inflammatory cytokines IL-6 and TNF-a were not detectable in the majority of untreated mice and in mice 7 days after anti-MPO IgG/LPS or LPS-only injection (data not shown). However, 1 day after disease induction with anti-MPO IgG/LPS, plasma levels of IL-6 and TNF-a were detectable, with higher overall levels in aged mice compared with young mice, although for TNF-a levels the difference did not reach statistical significance ( Figure 5B and C).
Aged mice display higher percentages of circulating neutrophils and activated monocytes after induction of anti-MPO IgG/LPS
We analysed neutrophils and monocytes and their activation status in peripheral blood by flow cytometry (Figure 6 ). The percentage of circulating neutrophils was higher in untreated Figure 6B ), whereas the percentage of monocytes was similar in both groups of mice ( Figure 6D ). After disease induction with anti-MPO IgG/LPS, the percentages of total neutrophils and activated neutrophils were substantially increased at Day 1 in both young and aged mice, returning to normal levels at Day 7 ( Figure 6B and C) . Although the percentage of circulating monocytes was largely unaffected after disease induction ( Figure 6D ), the percentage of activated monocytes increased in both aged and young mice, and was significantly higher in aged mice compared with young mice at Day 1 and Day 7 ( Figure 6E ). In addition, the percentages of monocytes and activated monocytes were higher in aged mice compared with young mice 7 days after LPS-only injection ( Figure 6D and E).
Aged mice display increased renal expression of inflammatory genes and endothelial adhesion molecules after induction of anti-MPO IgG/LPS Finally, we performed gene expression analysis on renal tissue (Table 2 ). For the pro-inflammatory cytokines IL-6, CXCL1 and TNF-a, no differences were observed between untreated young and aged mice. One day after disease induction by anti-MPO IgG/LPS, the expression of IL-6, CXCL1, TNF-a and IL1b was increased in young and aged mice. For IL-6, CXCL1 and IL-1b the increase was more pronounced in aged mice. Seven days after disease induction, gene expression levels of proinflammatory cytokines were normalized in young mice, but were still increased in aged mice. Gene expression levels of endothelial adhesion molecules ICAM-1 and E-selectin did not differ between untreated young and aged mice, while VCAM-1 expression was higher in aged mice. Gene expression levels of all endothelial adhesion molecules analysed were higher in aged mice compared with young mice 7 days after disease induction. We also evaluated the gene expression of the neutrophil and monocyte marker MPO, the macrophage marker CD68 and chemokine receptor type 2 (CCR2). In untreated mice, CCR2 expression was higher in aged than in young mice whereas after disease induction, the expression levels of CCR2 and MPO were higher in both groups. Gene expression levels of the kidney damage markers KIM-1 and NGAL were increased after disease induction, but no differences were observed between young and aged mice. Finally, we determined expression levels of senescence-related biomarkers, i.e. the ageing suppressor gene klotho, the tumour suppressor gene p53, and the cyclindependent kinase inhibitor gene p21. The expression levels of all these ageing-related genes were largely comparable between young and aged mice, except for klotho, which was decreased in aged mice compared with young mice 1 day after disease induction.
D I S C U S S I O N
AAV is a disease that occurs predominantly in older individuals. Previous studies have shown that older age is a predictor for worse prognosis and is consequently associated with higher mortality rates and increased morbidity [19, 20] . However, it is unclear if and how specific age-related alterations contribute to this increased vulnerability. The current study was designed to examine the effect of age on disease severity in a glomerulonephritis mouse model induced by anti-MPO IgG and LPS and how this relates to age-associated alterations in systemic components of the immune system and/or kidney-specific changes.
Collectively, our results demonstrate that, compared with young mice, aged mice develop more severe disease when subjected to anti-MPO IgG/LPS-induced glomerulonephritis, which may be attributed to age-related alterations in the immune system since it is well known that ageing is associated with reduced barrier function and profound changes in immune cell composition, distribution and function. This is exemplified by studies in mice demonstrating increased susceptibility of old mice to various pathogens [21] [22] [23] . Although ageing affects both the adaptive and innate arm of the immune system, it is likely that for our vasculitis model, age-related changes in innate immunity are more important since the model relies on the transfer of anti-MPO IgG and does not involve active immunization [15] . Pro-inflammatory cytokines, which in part reflect innate immune system activation, play an important role in AAV pathogenesis via priming of neutrophils and activation of the endothelium [24] . In both humans and mice, ageing is associated with low-grade systemic inflammation as evidenced by increased plasma TNF-a and IL-6 levels [25, 26] . Moreover, ageing has also been shown to exacerbate cytokine production in response to an acute inflammatory insult, such as LPS [27, 28] , which is in line with our observations that plasma levels of IL-6 in aged mice were higher after disease induction.
We also demonstrate that the percentage of circulating neutrophils is increased in aged mice after induction of anti-MPO IgG/LPS glomerulonephritis, which was paralleled by an increased influx of neutrophils in the kidney. In AAV, neutrophils are generally considered to be key effector cells mediating initial capillary injury. Neutrophils are abundantly present in the early necrotizing capillary lesions [29] [30] [31] . Moreover, many in vitro studies have shown that the interaction of ANCA with surface-expressed PR-3 or MPO on neutrophils results in their activation, making these cells more prone to adhere to the endothelium, causing the release of proteases and oxygen radicals that are injurious for the endothelium [32] . Importantly, neutrophil depletion in the anti-MPO IgG/LPS mouse model completely abrogates disease development, providing direct evidence for the crucial role of neutrophils in disease induction [29] .
In humans, it has been reported that neutrophil functions in the elderly may be compromised, showing reduced phagocytic capacity, reactive oxygen species production and intracellular killing, although contradictory reports also exist [33, 34] . However, studies in mice have demonstrated that neutrophils from aged mice do not show any functional impairment with respect to chemotaxis, respiratory burst and phagocytosis [23] . Therefore, it is unlikely that in our study the neutrophils from old mice were functionally impaired or were differentially Taken together, the increased disease severity in old mice may be explained by an increased production of proinflammatory cytokines in conjunction with increased numbers of circulating neutrophils promoting neutrophil-endothelial interactions, enhanced neutrophil activation and consequently aggravated vascular injury in these mice. An additional explanation may be that in aged mice, the clearance of neutrophils from sites of injury may be compromised. Studies using a burn injury model have shown that although neutrophil recruitment early after injury was similar between young and old mice, neutrophils persisted much longer in aged mice [35] . In our study, MPO gene expression levels were significantly higher in aged mice at Day 7 after disease induction suggesting persistence of neutrophils, which likely contributed to the increased renal injury observed.
Besides the involvement of neutrophils, recent studies indicate that macrophages also contribute to the early phases of necrotizing glomerulonephritis [36] . In addition, macrophages were functionally altered in aged mice [37] . Although we did not observe increased renal accumulation of macrophages in aged mice, we speculate that age-related functional alterations of macrophages may have contributed to more severe glomerulonephritis in aged mice. Apart from immune system alterations, kidney-specific changes upon ageing may also have contributed to increased disease severity. Ageing itself results in chronic low-grade inflammation that promotes organ damage which, in turn, may result in increased vulnerability of an organ for an ensuing inflammatory insult [38] . Accordingly, we found various inflammatory mediators including pro-inflammatory cytokines, chemokines and endothelial adhesion molecules to be upregulated in the kidneys of aged mice, which may have facilitated the recruitment and activation of inflammatory cells. Endothelial activation and pro-inflammatory cytokine expression was most pronounced in mice treated with anti-MPO IgG/LPS, suggesting that the kidneys of aged mice are 'primed' and more susceptible to a second hit leading to an exaggerated inflammatory response.
In addition to the inflammatory mediators in the kidney, we also examined the gene expression of senescence-related biomarkers. Recently, the secreted hormone klotho was identified as a central player at the ageing-inflammation interface [39] . In mice, deficiency of klotho causes a syndrome resembling human ageing, with increased renal IL-6 levels as well as systemic inflammation [40] . In an LPS-mediated acute inflammation model, renal klotho expression was down-regulated [41] . Moreover, in a mouse model of diabetes, klotho depletion has been found to contribute to increased inflammation [42] . In this study, both soluble and membrane-bound klotho was found to negatively regulate nuclear factor jB (NFjB) activation and suppress subsequent production of pro-inflammatory cytokines such as RANTES, MCP-1, IL-6 and IL-8, in response to TNF-a [42] . An anti-inflammatory effect of klotho has also been observed in human umbilical vein endothelial cells where klotho treatment attenuated TNF-a-induced monocyte adhesion, expression of adhesion molecules (ICAM-1 and VCAM-1) and NFjB activation both in vitro and ex vivo [43] . Therefore, it has been suggested that klotho is protective against ageing and/or senescence-associated inflammation. To date, klotho has not been investigated in AAV patients or in the mouse model of anti-MPO IgG/LPS-mediated glomerulonephritis. Here, we demonstrate a reduction of klotho gene expression in the anti-MPO IgG/LPS-mediated glomerulonephritis model, which was more pronounced in aged mice. This would be in line with a role of klotho in dampening inflammation being ineffective in the early phase of the anti-MPO mouse model. These observations warrant further studies into the role of klotho in AAV. For example, inducing anti-MPO/LPS-mediated glomerulonephritis in mice heterozygous for klotho gene expression in conjunction with the analyses of klotho levels in plasma and renal biopsies of AAV patients may aid in understanding the role of klotho in immunosenescence and AAV.
The anti-MPO mouse model used here closely mimics human pauci-immune necrotizing and crescentic glomerulonephritis with respect to urinary abnormalities and the development of crescentic glomerulonephritis. However, compared with previously reported data, both aged and young mice in our study developed a rather mild glomerulonephritis [16, 44] . The most plausible explanation for these discrepancies is differences in the pathogenic potential of anti-MPO antibody batches and the mouse strains used. Furthermore, in our study the same amount of anti-MPO antibody was injected into both young and aged mice. Since circulating blood volumes were higher in the heavier, aged mice this resulted in lower circulating anti-MPO antibody titres compared with young mice. However, despite these lower levels of anti-MPO antibodies, an increased disease severity was observed in aged mice. At Day 7, capillary necrosis was significantly more extensive in aged mice compared with young mice, whereas glomerular crescent formation was comparable between the two groups. This suggests a dissociation between capillary necrosis and glomerular crescent formation in the aged mice. As to the reasons underlying this dissociation, we can only speculate. First, since glomerular crescent formation and capillary necrosis are relatively mild in both age groups, differences between young and old mice may be subtle and our scoring system based on histopathology may not have been sensitive enough to detect small differences. Second, pathologic evaluation of glomerular crescent formation and capillary necrosis was performed at one time point, i.e. Day 7 after disease induction, and we cannot exclude the possibility that some of the glomeruli displaying capillary necrosis will eventually progress to crescent formation.
Another limitation of this study is that the disease is induced by a single injection of anti-MPO IgG, which results in acute renal disease. This is clearly different from ANCA-associated vasculitis in patients where the disease is progressive and involves both innate and adaptive immune responses [6] . It would therefore be interesting to evaluate if ageing has a similar effect on disease severity in, for example, the chronic rat model of anti-MPO glomerulonephritis that is induced by immunization with human-MPO [45] .
In conclusion, the results of the present study indicate that aged mice develop more severe clinical and pathological disease upon induction of anti-MPO IgG/LPS-mediated glomerulonephritis. Furthermore, our findings indicate that both agerelated changes in the immune system as well as kidney-specific changes upon ageing may contribute to this effect. Detailed clinical observations, analyses of biochemical parameters and renal biopsies in aged AAV patients could aid in further understanding of the age-dependent pathogenesis of AAV.
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